Noom expands weight loss program to include prescription drugs.

Noom, a weight loss startup, has launched a new program called Noom Med that can prescribe a new generation of weight-loss drugs, including GLP-1 agonists like Wegovy, to help certain members lose weight. The program is available to Noom Weight members with a BMI of at least 30 or those with a BMI of at least 27 if they have a weight-related medical condition like Type 2 diabetes. The membership fee for Noom Med is $49 per month, and the GLP-1 drugs are not covered by the membership fees.